相关实验视频
Updated: Jun 14, 2025

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
托西菲林用于内耳疾病
Ahmed Ramzi1, Subhia Maya2, Nadeen Balousha3
1Faculty of Medicine, Mansoura University, Mansoura, Egypt.
托西菲林在治疗内耳和耳方面表现有前途,通常有轻微的副作用. 然而,它对突然听力损失的有效性是不一致的,需要更多的研究才能提出最终的建议.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 药理学 药理学是指药理学的学科.
- 临床研究 临床研究
背景情况:
- 内耳疾病,包括听力损失,耳和头,很常见,但缺乏经批准的治疗方法.
- 托西菲林 (PTX) 已被研究用于耳和前庭状况,但其疗效和安全性需要系统审查.
研究的目的:
- 系统地审查pentoxifylline (PTX) 对内耳疾病的疗效和安全性.
- 根据现有研究,分析PTX对,听力损失和耳的影响.
主要方法:
- 截至2025年1月,对十多个全球数据库进行了全面搜索.
- 包括的研究集中在PTX在,听力损失和耳方面的明显或可归因结果上.
- 在分析的40项研究中,有15项随机对照试验 (RCT).
主要成果:
- 托西菲林在内耳方面表现出显著的积极结果.
- 对异形性突发感神经听力损失 (ISSNHL) 的结果是混合的,倾向于无效.
- PTX的疗效与金科比洛巴和皮质类固醇治疗耳的疗效相当,但副作用轻微.
结论:
- 托西菲林可以改善内耳和耳,但其在ISSNHL中的作用尚不确定.
- 这种药物在各种疗法中表现出良好的安全性.
- 目前的研究设计和严格性限制了制定强有力的治疗建议的能力.
更多相关视频
09:18A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection
Published on: March 8, 2017
06:55A Surgical Procedure for the Administration of Drugs to the Inner Ear in a Non-Human Primate Common Marmoset Callithrix jacchus
Published on: February 27, 2018
相关概念视频
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Heart Failure Drugs: Inotropic Agents
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...